compounded retatrutide Demand for Unapproved Weight-Loss Drug Surges on Social Media Retatrutide

This helps your clinician understand if your current dosage is right for you and gives you the opportunity to share any health changes, side effects, or medication preferences

Update on FDAs ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity [Internet]

There could also be opportunities for implementing more stringent UM criteria, making the plan ineligible for rebates but providing better trend control overall

Patients with Cardiovascular Risk Factors: Research suggests that GLP1 receptor agonists may provide cardiovascular benefits, including reduced risk of heart attack and stroke in patients with type 2 diabetes